Journal · Updated 2026-08-11
NC Medicaid and GLP-1s in 2026: The Coverage That Left and Came Back, Documented
By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify
The short answer
North Carolina is the rare state whose GLP-1 story runs in both directions inside eighteen months — and it currently ends in coverage. NC Medicaid began covering GLP-1s for weight management August 1, 2024 under its Outpatient Pharmacy Prior Approval Criteria; coverage was rolled back during 2025's budget fight; and per the department's December 19, 2025 bulletin, coverage was reinstated effective December 12, 2025 in accordance with the Governor's directive, reverting to the criteria in place as of September 30, 2025. The reinstatement applies to both NC Medicaid Direct and NC Medicaid Managed Care. Throughout the whole saga, one thing never lapsed: coverage of Wegovy and Zepbound for their FDA-approved indications other than weight loss — cardiovascular risk reduction among them — which the same bulletin reiterates. Here is the record, dated, and what it means at the pharmacy counter.
The documented timeline
The primary source is NC Medicaid's own bulletin stream at medicaid.ncdhhs.gov. August 1, 2024: weight-management coverage begins under the published "GLP-1s for Weight Management" prior-approval criteria — North Carolina joining the minority of states that affirmatively adopted the obesity benefit. 2025: the benefit is paused amid budget pressure — national policy trackers (the Delaware benefits office's December 2025 state-by-state review among them) list North Carolina alongside Colorado and West Virginia as states that rolled back or paused coverage during the year. December 12, 2025: reinstatement takes effect; the December 19 bulletin states that coverage "will be reverted to the coverage available as of Sept. 30, 2025," restoring access to medications previously available under the August 2024 criteria, across both delivery systems. That drop-and-restore arc is precisely why this site's standing rule for Medicaid questions is a dated primary source over any list — including, on principle, this page, which carries its capture date for the same reason.
What coverage looks like in practice
Reinstated coverage is prior-authorized coverage: the operative document is NC Medicaid's Outpatient Pharmacy Prior Approval Criteria for GLP-1s for Weight Management as of the September 30, 2025 snapshot — the criteria your prescriber's PA request is scored against, and the thing to pull (or have the office pull) before the appointment rather than after the denial. The general architecture of a strong request — BMI documentation, comorbidity records, any required step or lifestyle-program elements, and clean coding — is the PA guide's territory, and a denial routes to the appeal playbook. Because most North Carolina members sit in Managed Care, the plan's own pharmacy desk is the second call after the state criteria: the bulletin binds both systems, but plan-level processing is where individual requests live. And the non-weight doors — cardiovascular risk reduction for established heart disease, the diabetes indications, sleep apnea, kidney disease — remained open through the entire 2025 gap and remain open now; for members who qualify through one of them, the weight-management criteria are not even the relevant document.
What this record is for
Two uses. For the North Carolina member: as of this page's capture date, weight-management GLP-1 coverage is live, prior-authorized, and criteria-bound — start with the state criteria document and your plan's pharmacy line, and treat any secondhand "NC dropped coverage" claim as the stale version of a true 2025 story. For everyone else: North Carolina is the national object lesson that Medicaid GLP-1 coverage is a budget-cycle variable, not a fact of nature — it moved twice in one year, in opposite directions, each move landing mid-treatment for real members. The 2026 change ledger tracks every state move of this kind with dates and sources, and the Medicaid hub holds the fifty-state method. Both exist because this page's most important sentence is its least dramatic: check the current bulletin before you count on anything — including this.
Questions people ask
Does NC Medicaid cover Wegovy and Zepbound for weight loss in 2026?
Yes — coverage for GLP-1s for weight management was reinstated effective December 12, 2025 per NC Medicaid's bulletin, reverting to the September 30, 2025 prior-approval criteria, across both NC Medicaid Direct and Managed Care. Approval runs through the state's published PA criteria.
Did North Carolina Medicaid drop GLP-1 coverage?
It did, during 2025's budget pressure — after adopting the benefit August 1, 2024 — and then reinstated it effective December 12, 2025 under the Governor's directive. Both moves are documented in NC Medicaid's own bulletins, which is why dated primary sources outrank any list on this topic.
What are the requirements for GLP-1 coverage under NC Medicaid?
Whatever the Outpatient Pharmacy Prior Approval Criteria (as of the restored September 30, 2025 snapshot) specify — typically BMI and comorbidity documentation with prior-authorization review. Pull the current criteria document from medicaid.ncdhhs.gov before the appointment, and route denials through the standard appeal process.
Are the non-weight GLP-1 indications covered in North Carolina?
They never stopped being covered — the same bulletins reiterate coverage of Wegovy and Zepbound for FDA-approved indications other than weight loss, including cardiovascular risk reduction, throughout the 2025 gap. Members qualifying through a non-weight door don't need the weight-management criteria at all.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.